Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.

Hideyasu TsumuraNobumichi TanakaTomohiko OguchiTakuya OwariYasushi NakaiIsao AsakawaKazuyoshi IijimaHaruaki KatoIwao HashidaKen-Ichi TabataTakefumi SatohHiromichi Ishiyama

Published in: Radiation oncology (London, England) (2022)

The BCR-free rates did not significantly differ between patients treated with SEED-BT and those treated with RP for intermediate-risk prostate cancer even when they were directly compared using the surgical definition for BCR. SEED-BT and RP can be adequately compared for oncological outcomes.

Keyphrases

radical prostatectomy
prostate cancer
low dose
high dose
acute lymphoblastic leukemia
tyrosine kinase
radiation therapy
chronic myeloid leukemia
squamous cell carcinoma
locally advanced